Skip to content

Public FDA record

Z-1531-2021: ENDURITY Pulse Generator REF PM**** SN ********* St. Jude Medical Cardiac Rhythm Assurity and Endurity

Recall record Z-1531-2021 for St. Jude Medical, Cardian Rhythm Management Division. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1531-2021
Company in FDA record
St. Jude Medical, Cardian Rhythm Management Division
FDA classification date
May 7, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Due to a manufacturing issue associated with the mixing process of the epoxy used in the manufacture of pacemaker from years 2015 through 2018, the affected devices may malfunction caused by moisture ingress through the device header and feedthrough

Source facts

Action
On 10/5/2021, the firm notified additional customer via a "Safety Notification Update" letter due to finding additional affected products after March 2021. The instructions from the 3/15/2021 original letter still applies. Issue of the update remains, the issue is caused by intermittent incomplete mixing of epoxy during manufacture, which may allow moisture ingress into the pulse generator header. As a result, the potential for affected clinical impact has included loss of telemetry/communication, reduced battery longevity, loss of pacing, and/or shortened duration between Elective Replacement Indicator (ERI) and End of Service (EOS). Physicians are provided with Patient Management Recommendations/Guidelines that include: 1) Prophylactic generator replacement is not recommended. This is due to the very low rate of occurrence, and the low potential for patient harm when prompt replacement is performed following an unexpected ERI/EOS alert. 2) Routine follow-up should remain as per standard of care and clinical protocol. - During follow-up, review any impact to device function including measured battery voltage or any unexpected change in battery consumption. - Evaluate potential for risk in patients who are pacemaker dependent and unable to be reliably followed using remote monitoring. 3) Prompt replacement for devices that reach ERI or EOS unexpectedly or experience one of the clinical impacts listed above commensurate with the patient s underlying clinical condition. 4) When possible, monitor patients using Merlin.net to benefit from alert monitoring between routine device checks. For patients currently enrolled in Merlin.net, remind them of the importance of using remote monitoring. ERI and EOS alerts are currently monitored daily. 5) Share this notification with others in their organization, as appropriate. Should you have any questions about this notice, please contact Abbott Technical Support at 1-800-722-3774 (U.S.). Please work with your Abbott Representat
Initiated
2021-03-15
Root cause
Process control
Distribution
Worldwide distribution: U.S (nationwide) to states including.: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. O.U.S.( countries): [806 Amendment - after March 2021 - updated 3/20/2023] Algeria, Angola, Argentina, Aruba, Australia, Austria, Bahrain, Bangladesh, Belgium, Benin, Bolivia, Brazil, Bulgaria, Cameroon, Canada, Chile, Colombia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Germany, Guatemala, Hong Kong, Hungary, India, Ireland, Italy, Japan, Jordan, Korea, Lebanon, Lithuania, Luxembourg, Macau, Malaysia, Mexico, Montenegro, Morocco, Nepal, Netherlands, New Caledonia, New Zealand, Norway, Pakistan, Palestine, Panama, Paraguay, Peru Poland, Portugal, Qatar, Reunion, Romania, Saudi Arabia, Senegal, Servia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Venezuela, Vietnam, and Yemen.
Recall number
Z-1531-2021
Recall status
Open, Classified
CDRH record ID
186271
FDA classified
2021-05-07
Recall event number
87558

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗